Stocktwits on MSN
ATAI stock soars on track for best day on Trump psychedelics push and Wall Street cheers
Canaccord analyst Sumant Kulkarni raised the firm's price target on AtaiBeckley to $15 from $14 and kept a ‘Buy’ rating on ...
After President Donald Trump signed an executive order (1) aimed at fast-tracking research and access to psychedelic ...
Shares of psychedelic drug developers rose after Trump signed an executive order directing health regulators to speed up ...
U.S. President Donald Trump this week signed an executive order directing health regulators to speed reviews of psychedelic ...
The directive is expected to lead to fewer legal hurdles for psychedelic studies, increased funding, and potentially ...
Atai Life Sciences (NASDAQ:ATAI) is one of the best multibagger penny stocks to buy according to analysts. On July 29, Oppenheimer initiated coverage of the stock with an ‘Outperform’ rating and a ...
COMPASS Pathways (CMPS) stock jumped 25% after Trump's executive order on psychedelic research. Positive Phase 3 data boosts ...
NEW YORK and BERLIN, Jan. 04, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of ...
Atai Life Sciences N.V. (NASDAQ:ATAI) is one of the best healthcare penny stocks to buy now. On September 15, H.C. Wainwright reiterated a ‘Buy’ rating on the stock and a $15 price target. The ...
AtaiBeckley Inc (NASDAQ:ATAI) is among the must-buy penny stocks to invest in now. The stock has gained more than 180% over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results